65 -- TRANSFUSIONS

This is a COMBINED SYNOPSIS/SOLICITATION/NOTICE OF INTENT for commercial supplies prepared in accordance with the format in Subpart 12.6 and Part 13, as supplemented with additional information included in this notice. This announcement constitutes the only notice of intent and a written notice of intent WILL NOT be issued. The Department of Navy, Bureau of Medicine and Surgery, National Naval Medical Center, Acquisition Management Service, intends to negotiate on a sole source basis with Ortho Clinical Diagnostics for: DESCRIPTION QUANTITY UNIT OF ISSUE 0.8% SURGISCREEN 216 PG DELIVER 24 EACH MONTH JAN THRU SEPT 0.8% AFFIRMAGEN 216 PG DELIVER 24 EACH MONTH JAN THRU SEPT 0.8% RESOLVE PANEL A 6 PG DELIVER 2 EACH MONTH JAN THRU SEPT 0.8% RESOLVE PANEL B 9 PG DELIVER 1 EACH MONTH JAN THRU SEPT 0.8% RESOLVE PANEL C 9 PG DELIVER 1 EACH MONTH JAN THRU SEPT PROVUE ROUND BOTTLE 12 PG DILUENT (2)DELIVER 3 EACH MONTH JAN, APR, JUL & SEP 2008 PROVUE ROUND BOTTLE 28 PG DILUENT (2+)DELIVER 7 EACH MONTH JAN, APR, JUL & SEP 2008 PROVUE SOLUTION A 12 PG DELIVER 3 EACH MONTH JAN, APR, JUL & SEP 2008 PROVUE SOLUTION B 24 PG DELIVER 6 EACH MONTH JAN, APR, JUL & SEP 2008 ALBAQ-CHEK DELIVER 40 SE 4 SETS EACH MONTH JAN THRU SEPT 2008. The North American Industry Classification System (NAICS) code for this acquisition is 325413. This acquisition will be under the authority of Section 4202 Clinger Cohen Act of 1996, as set forth in FAR Part 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements. Solicitation questions shall be submitted in writing to [email protected]. This is NOT a request for competitive quotes. CLOSING DATE: 9:00 A.M. 26 DEC 2007 EST.